Patents by Inventor Niaz Banaei

Niaz Banaei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9557250
    Abstract: Embodiments of the present disclosure provide for particle-imprinted polymer films, methods of making particle-imprinted polymer films, methods for separating particles, devices or systems for separating particles, and the like.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: January 31, 2017
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Romana Schirhagl, Richard N. Zare, Kangning Ren, Niaz Banaei
  • Publication number: 20160113919
    Abstract: This disclosure provides a method of treating a subject infected with a mycobacteria of the M. tuberculosis complex or infected with an atypical mycobacterium. Aspects of the method include administering to a subject in need thereof a therapeutically effective amount of an enantiomerically pure (R)-chloroquine agent. The (R)-chloroquine agent may be an analog or derivate of chloroquine having a particular stereochemistry at the position located alpha to the amino-quinoline core of the chloroquine agent. Also provided are methods of inhibiting mycobacteria of the M. tuberculosis complex or other atypical mycobacteria in a cell. Kits and pharmaceutical compositions for practicing the subject methods are also provided.
    Type: Application
    Filed: October 20, 2015
    Publication date: April 28, 2016
    Inventors: Niaz Banaei, Jeffrey S. Glenn, Rajiv Lochan Gaur, Tran Van, Gary K. Schoolnik, Edward Pham
  • Patent number: 8771967
    Abstract: Improved assays for detecting the presence of a specific cell-mediated immune response in an individual are provided, where a sample comprising T cells and other cells of the immune system, usually a blood sample or derivative thereof, is contacted with test antigen(s) of interest in the presence of a pattern recognition receptor (PRR) agonist. The sample is incubated for a period of time sufficient to activate effector T cells; and release of immune effector molecule(s) is then detected. In some embodiments, the PRR is an agonist of a toll-like receptor (TLR) expressed by mature antigen presenting cells, including without limitation agonists TLR3 and TLR7, such as LPS, poly I:C, imiquimod, etc.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: July 8, 2014
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventor: Niaz Banaei
  • Publication number: 20130309657
    Abstract: Embodiments of the present disclosure provide for particle-imprinted polymer films, methods of making particle-imprinted polymer films, methods for separating particles, devices or systems for separating particles, and the like.
    Type: Application
    Filed: March 7, 2013
    Publication date: November 21, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Romana Schirhagl, Richard N. Zare, Kangning Ren, Niaz Banaei
  • Publication number: 20120129197
    Abstract: Improved assays for detecting the presence of a specific cell-mediated immune response in an individual are provided, where a sample comprising T cells and other cells of the immune system, usually a blood sample or derivative thereof, is contacted with test antigen(s) of interest in the presence of a pattern recognition receptor (PRR) agonist. The sample is incubated for a period of time sufficient to activate effector T cells; and release of immune effector molecule(s) is then detected. In some embodiments, the PRR is an agonist of a toll-like receptor (TLR) expressed by mature antigen presenting cells, including without limitation agonists TLR3 and TLR7, such as LPS, poly I:C, imiquimod, etc.
    Type: Application
    Filed: November 16, 2011
    Publication date: May 24, 2012
    Inventor: Niaz Banaei